What Pharmica Consulting does

Pharmica Consulting is identified in the firmographic record as a privately held, for-profit consulting firm founded in 2005 and headquartered in Sparta, United States, with 11-50 employees, offering global development, clinical operations, program management, and commercial services. However, the bulk of the detailed source data describes ProPharma (legal entity: ProPharma Group MIS Limited, registered in England and Wales), a separate life sciences consultancy with over 25 years of operating history, a globally distributed service portfolio, and a leadership team including a CCO and VP of HEOR.

The detailed ProPharma profile positions the firm as an end-to-end life sciences consulting partner, organized around seven core service lines: Regulatory Sciences (FDA and EMA consulting, MAH partnership, lifecycle management), CRO Services (multi-phase clinical research, biostatistics, medical writing), Quality & Compliance (GxP auditing, CSV, inspection readiness, AI/ML compliance), Pharmacovigilance (clinical and post-marketing drug safety, QPPV/LPPV, signal management), Medical Information (24/7/365 contact centers), FSP Solutions (embedded functional resourcing), and Digital Transformation (data strategy, validation). The firm serves pharmaceutical, biotechnology, and medical device organizations horizontally, with bespoke, engagement-based pricing undisclosed publicly.

The business operates on a professional services revenue model with direct enterprise sales, thought leadership marketing, and recurring client engagements spanning the full product lifecycle from nonclinical development through post-marketing pharmacovigilance. Recent strategic actions include the July 2026 launch of an AI-Assisted ANDA Submission Development capability, the introduction of QA/AI & ML Compliance Services, two senior leadership appointments in 2025, and three industry awards in 2024-2025. The unresolved discrepancy between the firmographic description of Pharmica Consulting as a small US firm and the substantive data describing ProPharma as a large global consultancy is a material data integrity issue that requires clarification before any investment decision.

Name

Pharmica Consulting

Legal name

ProPharma Group MIS Limited

Website

https://pharmicaconsulting.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharmica Consulting is recorded as a small US-based life sciences consultancy offering global development, clinical operations, program management, and commercial services; the detailed evidence describes ProPharma, a multi-service global life sciences consulting firm serving pharma, biotech, and medical device clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Other Management Consulting Services (541618), Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

Keywords

• Pharmaceutical consulting
• Clinical operations
• Regulatory consulting
• Drug development services
• Pharmacovigilance services

Headquarters

HQ city

Sparta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Professional Consulting Services: ProPharma generates revenue through providing specialized consulting services across regulatory sciences, clinical research, compliance, pharmacovigilance, and medical information. As a professional services organization, revenue is derived from client engagements throughout the full product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Pharmica Consulting provides global development, clinical operations, program management, and commercial services to pharmaceutical, biotechnology, and medical device organizations. The firm delivers end-to-end consulting across the full product lifecycle, spanning Regulatory Sciences, CRO Services, Quality and Compliance, Pharmacovigilance, Medical Information, FSP Solutions, and Digital Transformation.

Product overview

ProPharma offers a fully customizable, end-to-end suite of professional consulting services spanning the full pharmaceutical product lifecycle. The portfolio consists of seven core service lines: Regulatory Sciences (FDA/EMA regulatory consulting), CRO Services (full-service clinical research), Quality & Compliance (GxP compliance and validation), Pharmacovigilance Solutions (drug safety monitoring), Medical Information (24/7 contact centers), FSP Solutions (functional service provider), and Digital Transformation (technology enablement). These integrated services are designed to work together to support biotech, pharmaceutical, and medical device organizations from early development through post-market support.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Sciences Comprehensive regulatory consulting services supporting the full product lifecycle for drugs, biologics, medical devices, and diagnostics, including FDA and EMA regulatory consulting, FDA meeting support, expert witness services, European regulatory development, marketing authorization holder (MAH) partnership, lifecycle management, regulatory operations, advertising and promotional review, market access and reimbursement strategy, nonclinical development, and medical device solutions.
• CRO Services Full-service clinical research organization offering multi-phase clinical development and study execution for drugs, biologics, medical devices, and diagnostics, including full-service CRO, site and patient services, global medical writing and transparency, biostatistics and programming, and medical device services.
• Quality and Compliance Industry-leading quality and compliance consulting including GxP compliance and auditing, computer system validation, inspection readiness, program and project management, commissioning, qualification and validation, clinical quality assurance, medical device quality, cell and gene therapy consulting, and healthcare compliance services.
• Pharmacovigilance Solutions Full suite of pharmacovigilance services ensuring drug safety and consistency from clinical development through post-approval, including clinical pharmacovigilance, post-marketing pharmacovigilance, safety systems, QPPV and LPPV, case management, global literature review, signal management, periodic safety reports and risk management plans, global ICSR submissions, and regulatory intelligence.
• Medical Information Comprehensive medical information services including fully integrated 24/7/365 contact centers utilizing market-leading technologies and AI innovation, global contact center support, adverse event and product complaint intake and follow-up, patient support and commercial services, medical communications and content management, animal health services, REMS and RMP support, and consumer health services.
• FSP Solutions Functional service provider solutions bringing top-tier professionals as an extension of clients' internal teams across clinical development, including clinical operations, data sciences, biostatistics, medical writing and quality control, and decentralized clinical trials.
• Digital Transformation Technology solutions enabling life science organizations to navigate the development lifecycle, including digital blueprint, data strategy, technology services, and validation, quality and compliance support.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature1 record

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc: Global CRO and post-approval services provider offering clinical research, regulatory, and laboratory services. Direct overlap with ProPharma's clinical operations and regulatory consulting offerings, particularly for biotech and medical device sponsors.
• IQVIA: Largest global CRO and life sciences consulting provider offering regulatory, clinical, real-world evidence, and technology services across the full product lifecycle. Comparable to ProPharma in regulatory, clinical, PV, and commercial service lines, but with vastly greater scale.
• Labcorp Drug Development (now Fortrea): Full-service CRO offering clinical, central lab, and regulatory services spun out from Labcorp. Comparable to ProPharma across clinical, regulatory, and lifecycle management, with stronger lab-services adjacency.
• Parexel International: Major global CRO providing clinical research, regulatory consulting, pharmacovigilance, and commercialization services to pharma and biotech. Overlaps directly with ProPharma's CRO, regulatory, and PV service lines, but serves much larger client programs.
• Syneos Health: Biopharmaceutical services organization combining CRO, contract commercial, and consulting. Overlaps with ProPharma's CRO, regulatory, FSP, and market access service lines for pharma/biotech clients.
• Charles River Laboratories: Provides CRO, preclinical, manufacturing, and quality services to biopharma. Overlaps with ProPharma on CRO, quality & compliance, and discovery/preclinical-support consulting for pharma/biotech clients.

Others

• Veeva Systems: Cloud-based life sciences software provider for regulatory, quality, clinical, and medical information functions. Adjacent/ecosystem peer to ProPharma's services, increasingly enabling or competing with its regulatory and PV delivery via AI-augmented platforms.

Direct peers

• Worldwide Clinical Trials: Mid-tier global CRO focused on complex therapeutic areas including oncology, CNS, and rare disease. Direct competitor to ProPharma in regulatory, clinical, and PV services for small-to-mid-biotech sponsors.
• Medpace: Mid-sized CRO focused on full-service clinical development for pharmaceutical and medical device sponsors with a relationship-driven operating model. Closely comparable to ProPharma's CRO and FSP offerings and target biotech/pharma customer base.

Emerging players

• KPMG Life Sciences Regulatory Practice: Big Four advisory firm with a regulatory and quality compliance practice serving pharma, biotech, and medical device manufacturers. Overlaps with ProPharma's quality & compliance and regulatory consulting franchises, particularly for enterprise clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/pharmica
• LinkedInlinkedin.com/company/pharmica-consulting-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmica Consulting